NMN36000 800 mg Capsules PLUS 1 bottle
NMN36000 Capsules PLUS
Manufacturer
Harvard Apparatus Regenerative Technology
Harvard Apparatus Regenerative Technology Co., Ltd.
Main Ingredients — Amount per 2 Capsules
NMN (β-Nicotinamide Mononucleotide) — 800 mg
PQQ — 20 mg
NAC (N-Acetylcysteine) — 20 mg
Directions for Use — Product Specification
Take 2 capsules daily before breakfast.
90 capsules per bottle
Shelf Life — Storage
36 months
Store in a cool, dry place. Keep out of reach of children.
Precautions
Pregnant or breastfeeding women, or individuals with other medical conditions, should refrain from use and consult a physician or qualified healthcare professional before use. This product is not recommended for patients with cancer or tumors.
Features11
No reviews yet. Be the first to review this product.
Fast & Reliable Shipping - Orders are processed within 24-48 hours (excluding weekends & holidays). Estimated delivery within 3-7 business days (depending on location). We offer international shipping to most countries.
Hassle-Free Returns & Exchanges - You can return items within 30 days of delivery. Items must be unused, in original packaging, with all accessories included. Once we receive and inspect your return, a refund will be issued to your original payment method. Considering this is a food supplement, we do not accept returns on any opened products.
NMN36000 Capsules PLUS
Manufacturer
Harvard Apparatus Regenerative Technology
Harvard Apparatus Regenerative Technology Co., Ltd.
Main Ingredients — Amount per 2 Capsules
NMN (β-Nicotinamide Mononucleotide) — 800 mg
PQQ — 20 mg
NAC (N-Acetylcysteine) — 20 mg
Directions for Use — Product Specification
Take 2 capsules daily before breakfast.
90 capsules per bottle
Shelf Life — Storage
36 months
Store in a cool, dry place. Keep out of reach of children.
Precautions
Pregnant or breastfeeding women, or individuals with other medical conditions, should refrain from use and consult a physician or qualified healthcare professional before use. This product is not recommended for patients with cancer or tumors.
